Jeffrey S. Weber, MD, PhD, Laura and Isaac Perlmutter Professor of Oncology, Department of Medicine, NYU Grossman School of Medicine, deputy director, Perlmutter Cancer Center, codirector, Melanoma Research Program, NYU Langone Health, discusses unmet needs in ocular and mucosal melanoma.
Video Reports
Using ctDNA to Monitor Patients With Melanoma
John Kirkwood, MD, PhD: There are 2 arenas. First, the measurable active disease where we can make correlations much quicker because those patients…
Dr. Janku on the Efficacy of Ripretinib in KIT-Mutated Melanoma
Filip Janku, MD, PhD, discusses the results form a phase 1 study (NCT02571036) of ripretinib (Qinlock), a broad-spectrum KIT and PDGFRA inhibitor, in patients with KIT-mutated or KIT-amplified melanoma.
Future Management of Uveal Melanoma
Richard D. Carvajal, MD: Marlana, this has been a great conversation. Let’s close with future directions.